Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
gemcitabine and cisplatin; docetaxel, cisplatin and fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
gemcitabine,nimotuzumab, toripalimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
glutamine combined with thalidomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis Oral
1 trial -
golidocitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral T Cell Lymphoma
1 trial -
granules for suspension, N-Acetyl-L-Leucine
Intrabio Ireland Limited
Ataxia Telangiectasia
1 trial -
individual lactation counseling and educational material
Hospital Authority, Hong Kong
Breastfeeding
1 trial -
induced moderate hypothermia
Hospital Authority, Hong Kong
Traumatic Brain Injury
1 trial -
internal mammary nodal irradiation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
iron isomaltoside(Monoferยฎ)
Hospital Authority, Hong Kong
Anemia, Iron-Deficiency
1 trial -
laser acupuncture
Hospital Authority, Hong Kong
Postpartum Weight Retention
1 trial -
mCapOX plus Cetuximab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer (CRC)
1 trial -
mRNA-1010
Moderna Biotech Spain
Seasonal Influenza
1 trial -
mRNA-1647, Sodium Chloride 0.9%, Solution for Injection
Moderna Biotech Spain
Cytomegalovirus Infection (CMV)
1 trial -
magnetic stimulation
Hospital Authority, Hong Kong
Neuropathic Pain
1 trial -
maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir
Takeda
Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)
1 trial -
metformin
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
methylprednisolone
Ultragenyx UK Limited
Spinal Cord Injury
1 trial -
misoprostol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Labor Induction
1 trial -
mitomycin C-based hyperthermic intraperitoneal chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
mitoxantrone liposome, Ara-Cytarabine and azacitidine
The First People's Hospital of Lianyungang
Acute Myeloid Leukaemia
1 trial -
mosapride citrate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Constipation
1 trial -
mycophenolate mofetil 2 g per day
The First People's Hospital of Lianyungang
Lymphocytic Myocarditis (Disorder)
1 trial -
nab-paclitaxel combined with carboplatin
The First People's Hospital of Lianyungang
Epithelial Ovarian Carcinoma Stage III
1 trial -
neoadjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epithelial Ovarian Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources